R. Pohl

Hepatitis C virus dynamics and cellular gene expression in uPA‐SCID chimeric mice with humanized livers during intravenous silibinin monotherapy

N. Hiraga, H. Dahari, C. Tateno, 2016, Journal of viral hepatitis.

Sustained virological response with intravenous silibinin: individualized IFN‐free therapy via real‐time modelling of HCV kinetics

Harel Dahari, Gali Weiss, Massimo D'Amato, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Author manuscript, published in "Gastroenterology 2010;138(3):1112-22" DOI: 10.1053/j.gastro.2009.11.053 SILIBININ AND RELATED COMPOUNDS ARE DIRECT INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE

J. Pawlotsky, C. Wychowski, Ralf-Torsten Pohl, 2010 .

The use of mistletoe extracts in cancer patients

U. Mengs, R. Pohl, 2013, Zeitschrift für Phytotherapie.

Legalon® SIL: The Antidote of Choice in Patients with Acute Hepatotoxicity from Amatoxin Poisoning

Ralf-Torsten Pohl, U. Mengs, Todd Mitchell, 2012, Current pharmaceutical biotechnology.

OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE

J. Pawlotsky, A. Ahmed-Belkacem, C. Pallier, 2010 .

Understanding silibinin's modes of action against HCV using viral kinetic modeling.

Harel Dahari, Jeremie Guedj, Alan S Perelson, 2012, Journal of hepatology.